R. Aron English - May 6, 2021 Form 4/A - Amendment Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Signature
/s/ Aron R. English
Stock symbol
ANEB
Transactions as of
May 6, 2021
Transactions value $
$4,999,750
Form type
4/A - Amendment
Date filed
5/17/2021, 09:47 PM
Date Of Original Report
May 7, 2021
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANEB Common Stock, par value $0.001 per share Award $5M +714K +27.16% $7.00 3.34M May 6, 2021 22NW Fund, LP F1
holding ANEB Common Stock, par value $0.001 per share 4.65M May 6, 2021 Pharma Investors, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Persons with the U.S. Securities and Exchange Commission on May 7, 2021. The prior Form 4 is hereby corrected to state that the entity that directly holds the securities is 22NW Fund, LP, not 22NW, LP. In addition, the prior Form 4 is hereby corrected to state that the amount of securities purchased in the transaction on May 6, 2021 is 714,250, not 714,286. Accordingly, the total amount of shares owned by 22NW Fund, LP is 3,343,565. Mr. English, as the Manager of 22NW Fund GP, LLC, which is the General Partner of 22NW Fund, LP, may be deemed to beneficially own the securities owned directly by 22NW Fund, LP.